Identity
- Security key
- 13510
- Ticker
- CLYM
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-08-10
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CLYM
Detail
Enriched 2026-08-14 20:47
- Market cap
- $826,507,709.45
- Shares outstanding (class)
- 57,436,255
- Shares outstanding (weighted)
- 57,436,255
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 29
- Location
- WELLESLEY HILLS, MA
- Homepage
- https://www.climbbio.com
- Description
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Market cap and share counts drift.